$RMED News

Last published 3y ago

3y agoRMEDReminder: Ra Medical Systems Announces Name and Ticker Symbol ChangesACCESS NewswireName change to Catheter Precision, Inc. is effective on August 17, 2023, with trading under new ticker symbol VTAK to begin on August 18, 2023FORT MILL, SC / ACCESSWIRE / August 17, 2023 / Ra Medical Systems, Inc.
3y agoRMEDRa Medical Systems Announces Allowance of New Closure Device PatentACCESS NewswireFirst patent out of six applications on file for LockeT productFORT MILL, SC / ACCESSWIRE / August 14, 2023 / Ra Medical Systems, Inc. today announced that it has received notification of allowance of the
3y agoRMEDRa Medical Systems Announces Proposed Name and Ticker Symbol ChangesACCESS NewswireName change to Catheter Precision, Inc. expected to become effective on August 17, 2023, with trading under new ticker symbol VTAK expected to begin on August 18, 2023FORT MILL, SC / ACCESSWIRE / July 31, 2023 / Ra
3y agoRMEDRa Medical System's Electrophysiology Division Has Increased Demand for its Non-invasive Mapping SystemACCESS NewswireNew Hospitals Approve Use of VIVO and Existing Customers Increase UtilizationFORT MILL, SC / ACCESSWIRE / July 24, 2023 / Ra Medical Systems, Inc. announced today that there is an increase in
3y agoRMEDRMED's LockeT Device Utilized in Structural Heart ProceduresACCESS NewswireProvides Evidence of Efficacy in Large Diameter Sheath Procedures, Expanding Use Beyond Electrophysiology MarketFORT MILL, SC / ACCESSWIRE / July 6, 2023 / Ra Medical Systems, Inc. today announced
3y agoRMEDRMED's Electrophysiology Division Expands International DistributionACCESS NewswirePrepares for the CE Mark and International Launch of LockeT in Third Quarter 2023FORT MILL, SC / ACCESSWIRE / July 3, 2023 / Ra Medical Systems, Inc. has announced that it has undertaken a strong effort to
3y agoRMEDRMED's Electrophysiology Division Submits Data for CE Mark on LockeT Expects to Receive CE Mark in Third Quarter, 2023ACCESS NewswireFORT MILL, SC / ACCESSWIRE / June 28, 2023 / Ra Medical Systems, Inc. today announced that its Catheter Precision subsidiary has submitted to its European Notified Body the data necessary for determination of
3y agoRMEDRa Medical's Electrophysiology Division Announces First Hospital to Complete 100 Procedures Using the VIVO SystemACCESS NewswireFORT MILL, SC / ACCESSWIRE / June 12, 2023 / Ra Medical Systems, Inc. announced today that its wholly owned subsidiary, Catheter Precision, Inc., has had its first customer, Heart Hospital of New
3y agoRMEDRa Medical Systems Announces First Quarter ResultsACCESS NewswireFORT MILL, SC / ACCESSWIRE / June 2, 2023 / Ra Medical Systems, Inc. today announced financial and company highlights for the first quarter ended March 31,2023. Among the quarter highlights are the
3y agoRMEDRa Medical Systems Receives Notice from NYSE American Regarding Late Filing of Quarterly Report on Form 10-QACCESS NewswireFORT MILL, SC / ACCESSWIRE / May 30, 2023 / Ra Medical Systems, Inc. announced today that on May 23, 2023, the Company received a notice from NYSE Regulation stating that the Company
3y agoRMEDRa Medical Systems Announces Delayed 10-Q FilingACCESS NewswireFORT MILL, SC / ACCESSWIRE / May 22, 2023 / Ra Medical Systems, Inc. announced today that it will not file its Quarterly Report for the quarter ended March 31, 2023 within the filing deadline
3y agoRMEDRa Medical Systems Provides First Corporate Update Since MergerACCESS NewswireSales and Clinical Field Force Onboarded and Fully TrainedFirst Quarter Results to be Announced on May 22, 2023FORT MILL, SC / ACCESSWIRE / May 16, 2023 / Ra Medical Systems, Inc. announced the first
3y agoRMEDCatheter Precision Announces Enrollment of 125 Subjects in the VIVO EU RegistryACCESS NewswireFORT MILL, SC / ACCESSWIRE / May 9, 2023 / Ra Medical Systems announced that its subsidiary, Catheter Precision, has enrolled 125 subjects into its European observational registry. The study will continue to enroll
3y agoRMEDCORRECTION: Ra Medical Electrophysiology Division Participates in EHRA CongressACCESS NewswireThis press release corrects and replaces one issued previously correcting the title of David Jenkins.FORT MILL, SC / ACCESSWIRE / April 17, 2023 / Ra Medical Systems, Inc. announced today that its wholly
3y agoRMEDRa Medical Announces Resignation of CEOACCESS NewswireBoard Committee Seeking ReplacementFORT MILL, SC / ACCESSWIRE / April 18, 2023 / Ra Medical Systems, Inc. announced today the resignation of its CEO, Will McGuire, for personal reasons. The resignation will
3y agoRMEDRa Medical Electrophysiology Division is Participating in EHRA CongressACCESS NewswireFORT MILL, SC / ACCESSWIRE / April 17, 2023 / Ra Medical Systems, Inc. announced today that its wholly owned subsidiary, Catheter Precision, Inc., participates in the European Heart Rhythm Association .
3y agoRMEDRa Medical Systems Announces Change in Chief Financial Officer Position Previous Acting CFO Position Replaced with Permanent AppointmentACCESS NewswireFORT MILL, SC / ACCESSWIRE / March 30, 2023 / Ra Medical Systems, Inc. today announced the appointment of Steven Passey as Chief Financial Officer effective April 1, 2023, replacing Brian Conn, who has been
3y agoRMEDRa Medical Systems Announces Closing of $8 Million Private PlacementACCESS NewswireFT. MILL, SC / ACCESSWIRE / March 27, 2023 / Ra Medical Systems, Inc. today announces that it has closed its previously announced private placement, which generated $8 million in gross proceeds.David Jenkins,
3y agoRMEDRa Medical Systems Announces Results of Special Meeting of StockholdersACCESS NewswireIntends to close on $8 million financingFT. MILL, SC / ACCESSWIRE / March 21, 2023 / Ra Medical Systems, Inc. announces that at its virtual Special Meeting of Stockholders held today, the stockholders
3y agoRMEDRa Med Division Announces Product Launch of LockeT DeviceACCESS NewswireInitial Shipments to Begin This WeekFORT MILL, SC / ACCESSWIRE / February 14, 2023 / Ra Medical Systems, Inc. announced today that its wholly owned subsidiary, Catheter Precision, Inc., has launched
3y agoRMEDRa Medical Systems Announces Date of Special Shareholder MeetingACCESS NewswireFORT MILL, SC / ACCESSWIRE / February 10, 2023 / Ra Medical Systems today announced the date of March 21, 2023 as the date of its special shareholder meeting. Shareholders of record as of February 3, 2023 are
3y agoRMEDRa Medical Systems Announces the Presentation of Clinical Data at the European Heart Rhythm Association CongressBusiness WireFour abstracts with clinical data supporting use of Catheter Precision's VIVO™ technology accepted for presentation at leading electrophysiology conference Ra Medical Systems, Inc. (NYSE:RMED) (Ra Medical), a
3y agoRMED STJ PMRRa Medical Systems Realigns Its Board of DirectorsBusiness WireRa Medical Systems (NYSE:RMED) announces a realignment of its board of directors in conjunction with the recently announced merger with Catheter Precision, Inc. David Jenkins has joined the board as Executive Chairman
3y agoABT MDT RMEDRa Medical Systems Completes Merger with Catheter PrecisionBusiness WireMedtech Veteran and Catheter Precision CEO and Founder David Jenkins to Serve as Executive Chairman Enters Agreements to Raise up to $9.3 Million in Equity
3y agoRMEDRa Medical Systems Regains Compliance with NYSE American Continued Listing StandardsBusiness WireRa Medical Systems, Inc. (NYSE:RMED) ("Ra Medical" or the "Company") announces that it has received notification from the NYSE American LLC ("NYSE American") that the Company has regained compliance with the NYSE
3y agoBSGM IRTC MDT NMTC+1Global Cardiac Arrhythmia Monitoring Devices Market Size Expected to Reach $11.4 Billion by 2030PR NewswireFinancialNewsMedia.com News Commentary PALM BEACH, Fla, Dec. 14, 2022 /PRNewswire/ -- A cardiac arrhythmia is an irregular heartbeat caused by incorrect electrical signals that govern the beats of the heart. The improper
3y agoRMEDCatheter Precision's VIVO™ System Used in More Than 800 Procedures in Leading U.S. and European HospitalsBusiness WireCatheter Precision, Inc., a medical device and technology company focused on cardiac electrophysiology, announces that more than 800 procedures have been performed in a number of leading U.S. and European hospitals
3y agoRMEDCatheter Precision's VIVO™ Systems Used in More Than 20 Procedures at NYU Langone HospitalBusiness WireCatheter Precision, Inc., a medical device and technology company focused on cardiac electrophysiology, announces the completion of more than 20 procedures at NYU Langone Hospital utilizing the VIVO System that enables
3y agoMDT RMEDRa Medical Systems Reports Third Quarter 2022 Financial ResultsBusiness WireRa Medical Systems, Inc. (NYSE:RMED) ("Ra Medical" or the "Company") reports financial results for the three and nine months ended September 30, 2022 and provides a business update. On September 9, 2022, Ra Medical
4y agoRMEDCatheter Precision Expands U.S. Customer Base for VIVO™ for Non-invasive Arrythmia Location Detection Before Ventricular Ablation ProceduresBusiness WireCatheter Precision, Inc. ("Catheter Precision"), a medical device company focused on cardiac electrophysiology, announces receipt of three commercial orders in the past 60 days as usage of the device continues to
4y agoRMEDRa Medical Systems Raises $7.6 Million Through Completed At-The-Market FacilityBusiness WireRa Medical Systems, Inc. (NYSE:RMED) ("Ra Medical" or the "Company") announces the completion of its at-the-market (ATM) facility, raising gross proceeds of $7.6 million. The Company sold 1,072,246 shares of common
4y agoRMEDCatheter Precision Files a Method-of-Use U.S. Patent Application for its VIVO™ TechnologyBusiness WireCatheter Precision, Inc. ("Catheter Precision"), a medical device company focused on cardiac electrophysiology, announces the filing of a new U.S. patent application for its VIVO™ (View Into Ventricular Onset) technology, as it continues its focus on
4y agoRMEDCatheter Precision's VIVO™ Technology to be Featured in Three Presentations at the Global Society of Cardiac Robotic Navigation Annual MeetingBusiness WireCatheter Precision, Inc., a medical device and technology company focused on cardiac electrophysiology, announces that its lead product, VIVO™ (View Into Ventricular Onset), will be featured in presentations by three physicians working in the field of
4y agoRMEDCatheter Precision Names Fatih Ayoglu as Business Development Manager—EMEABusiness WireCatheter Precision, Inc., a medical device and technology company focused on cardiac electrophysiology, announces the appointment of Fatih Ayoglu to the newly created position of Business Development Manager—EMEA. Mr. Ayoglu will oversee clinical and
4y agoMDT RMEDRa Medical Systems Announces Results of its Special Meeting of Stockholders and a 1-for-50 Reverse Stock SplitBusiness WireRa Medical Systems, Inc. (NYSE:RMED) ("Ra Medical" or the "Company") announces that at its virtual Special Meeting of Stockholders held today, the Company's stockholders approved all three proposals on the proxy filed with the Securities and Exchange Co
4y agoMDT RMEDRa Medical Systems Enters Into Definitive Merger Agreement with Catheter PrecisionBusiness WireCombined Company Dedicated to Developing and Delivering Novel Technologies and Solutions to Improve the Lives of Patients with Cardiac Arrhythmias Medtech Veteran David Jenkins to Lead Merged Company Ra Medical Systems, Inc. (NYSE:RMED) ("Ra Medic
4y agoRMEDRa Medical Systems Receives NYSE American NoticeBusiness WireRa Medical Systems, Inc. (NYSE:RMED) ("Ra Medical" or the "Company) announces that on August 31, 2022, it received a notice (the "Notice") that the NYSE American LLC has determined the Company's securities have been selling at a low price per share for
4y agoRMEDRa Medical Systems Reports Second Quarter 2022 Financial ResultsBusiness WireRa Medical Systems, Inc. (NYSE:RMED) ("Ra Medical" or the "Company") reports financial results for the three and six months ended June 30, 2022 and provides a business update. "We are continuing to pursue a potential merger with a privately held comp
4y agoRMEDRa Medical Systems Provides Update on its Annual FilingsBusiness WireRa Medical Systems, Inc. (NYSE:RMED) ("Ra Medical" or the "Company) announces that its audited consolidated financial statements for the fiscal year ended December 31, 2021 included in the Company's Form 10-K filed with the Securities and Exchange Commi
4y agoRMEDRa Medical Systems Enters Into Agreements to Raise $6.2 Million Through Previously Issued Warrants and Plans Strategic Merger with Catheter Precision Inc.Business WireRa Medical Systems, Inc. (NYSE:RMED) ("Ra Medical" or the "Company) announces a reduction in the exercise price of all existing warrants that were issued in the February 2022 public offering, consisting of Series A Warrants and Series B Warrants, from $
4y agoRMEDRa Medical Systems Appoints Brian D. Conn Interim Chief Financial OfficerBusiness WireRa Medical Systems, Inc. (NYSE:RMED) ("Ra Medical" or the "Company"), a medical device company focusing on developing its excimer laser system to treat vascular diseases, announces the appointment of Brian D. Conn as interim Chief Financial Officer, eff
4y agoRMEDRa Medical Systems Receives FDA 510(k) Clearance for the DABRA 2.0 CatheterBusiness WireBoard of Directors continues its review of strategic alternatives to determine the Company's optimal path forward Ra Medical Systems, Inc. (NYSE:RMED) ("Ra Medical" or the "Company"), a medical device company focusing on developing its excimer laser
4y agoRMEDRa Medical Systems Reports First Quarter 2022 Financial ResultsBusiness WireConference call begins at 4:30 p.m. Eastern time today Ra Medical Systems, Inc. (NYSE:RMED) ("Ra Medical" or "the Company"), a medical device company focusing on developing its excimer laser system to treat vascular disease, reports financial results
4y agoRMEDRa Medical Systems to Report First Quarter 2022 Financial Results on May 16, 2022Business WireRa Medical Systems, Inc. (NYSE:RMED) announces that it will report financial results for the three months ended March 31, 2022 after market close on Monday, May 16. Ra Medical management will hold an investment community conference call that day at 1:30
4y agoRMEDRa Medical Systems Granted U.S. Patent for Laser Ablation Catheters with Expanded Ablation AreaBusiness WireRa Medical Systems, Inc. (NYSE:RMED), a medical device company focusing on developing its excimer laser system to treat vascular diseases, announces the United States Patent and Trademark Office has granted the company a patent for liquid-filled laser a
4y agoRMEDRa Medical Systems Achieves Milestone of 100 Subjects Enrolled in its Pivotal Atherectomy Clinical StudyBusiness WireRa Medical Systems, Inc. (NYSE:RMED), a medical device company focusing on developing its excimer laser system to treat vascular diseases, announces the achievement of a milestone with the enrollment of 100 subjects in its pivotal clinical study to eval
4y agoRMEDRa Medical Systems Reports 2021 Fourth Quarter and Full Year Financial ResultsBusiness WireConference call begins at 4:30 p.m. Eastern time today Ra Medical Systems, Inc. (NYSE:RMED), a medical device company focusing on developing its excimer laser system to treat vascular disease, reports financial results for the three months and full y
4y agoRMEDRa Medical Systems to Report 2021 Fourth Quarter and Full Year Financial Results on March 23, 2022Business WireRa Medical Systems, Inc. (NYSE:RMED) announces that it will report 2021 fourth quarter and full year financial results after market close on Wednesday, March 23. Ra Medical management will hold an investment community conference call that day at 1:30 p.
4y agoRMEDRa Medical Systems Files 510(k) Application for the DABRA Catheter with Braided Overjacket and Six-Month Shelf LifeBusiness WireRa Medical Systems, Inc. (NYSE:RMED), a medical device company focusing on developing its excimer laser system to treat vascular diseases, announces the filing of a 510(k) application with the U.S. Food and Drug Administration (FDA) for the company's ne
4y agoRMEDRa Medical Systems Provides an Update on Enrollment in Its Pivotal Atherectomy Clinical TrialBusiness WireRa Medical Systems, Inc. (NYSE:RMED), a medical device company focused on developing its excimer laser system to treat vascular diseases, announces enrollment has reached 95 subjects in its pivotal clinical trial to evaluate the safety and effectiveness